General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ghosh-Laskar S et al. - The 5-year overall survival (OAS) was 80% and disease-free survival was 65%. Grade III or more neutropenia was seen in 15%. Results of Ifosfamide–Cisplatin combination as a NACT in advanced NPC have been quite encouraging and need to be exploited further.


Related Articles

Seliciclib in malignancies
Expert Opinion on Investigational Drugs, 11/30/09    Relevance Score: 62%

Screening for Cancer
MedLinePlus, 11/02/09    Relevance Score: 49%

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 11/30/09    Relevance Score: 48%

Obesity responsible for 100,000 cancer cases annually
CNN Health, 11/06/09    Relevance Score: 48%

Obesity linked to specific cancers
Internet Source, 11/05/09    Relevance Score: 48%

Today in Nose...keeping you current

Rhinosinusitis and Comorbidities
Current Allergy and Asthma Reports, 03/18/10

Nasal Secretion Concentrations of IL-5, IL-6, and IL-10 in Children With and Without Upper Respiratory Tract Viruses
Archives of Otolaryngology, 03/18/10

Fluticasone Reverses Oxymetazoline Induced Tachyphylaxis of Response and Rebound Congestion
American Journal of Respiratory and Critical Care Medicine, 03/17/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address